SCHEMBL61052

SCHEMBL61052

COC(=O)[C@@H](N)CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8814797 1.00
SCHEMBL937480 1.00
Hydrochloric Acid SCHEMBL28348104 0.98 LTA4H (0.37)
Hydrochloric Acid SCHEMBL938410 0.98 LTA4H (0.37)
Hydrochloric Acid SCHEMBL11344095 0.98 LTA4H (0.37)
SCHEMBL11776470 0.87 SMN1; SMN2 (0.42)
SCHEMBL24075464 0.86 CA1 (0.39)
SCHEMBL12534327 0.86 CA1 (0.39)
SCHEMBL930523 0.85 ZDHHC7 (0.40)
SCHEMBL930524 0.85 ZDHHC7 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119158034-A Bicyclic peptide ligands specific for conjugated protein-4 拜斯科技术开发有限公司 2024-12-20 CN claimed
US-20230405134-A1 NOVEL PROTAC CHIMERIC COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING, AMELIORATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION POSTECH Research and Business Development Foundation (KR) 2023-12-21 US claimed
WO-2022005252-A1 NOVEL PROTAC CHIMERIC COMPOUND, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME FOR PREVENTING, AMELIORATING, OR TREATING DISEASES THROUGH TARGET PROTEIN DEGRADATION 포항공과대학교 산학협력단 2022-01-06 WO claimed
EP-3752174-A1 FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF University of Florida Research Foundation, Incorporated (US) 2020-12-23 EP claimed
WO-2019160910-A1 FIBROBLAST GROWTH FACTOR ANALOGS AND USES THEREOF UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) 2019-08-22 WO claimed
CN-1186332-C Novel thyroid receptor ligands and method II KAROBIO AB (SE) 2005-01-26 CN claimed
CN-1337953-A Novel thyroid receptor ligands and method II KAROBIO AB (SE) 2002-02-27 CN claimed
US-12630561-B2 Tricyclic derivatives inhibitor, preparation method, and applications thereof JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2026-05-19 US disclosed
US-20250382380-A1 D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF ARCELLX INC (US) 2025-12-18 US disclosed
US-20250353908-A1 D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF ARCELLX INC (US) 2025-11-20 US disclosed
US-20250320271-A1 D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF ARCELLX INC (US) 2025-10-16 US disclosed
EP-4626912-A2 D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF Arcellx, Inc. (US) 2025-10-08 EP disclosed
US-12421291-B2 D-domain containing polypeptides and uses thereof ARCELLX, INC. (US) 2025-09-23 US disclosed
EP-1599096-A2 HETERO SUBSTITUED SODIUM CHANNEL BLOCKERS Parion Sciences, Inc. (US) 2005-11-30 EP disclosed
CN-1602326-A Lipid-polymer-conjugates YAMANOUCHI EUROP BV (NL) 2005-03-30 CN disclosed
CN-1186332-C Novel thyroid receptor ligands and method II KAROBIO AB (SE) 2005-01-26 CN disclosed
WO-2004073629-A2 HETERO SUBSTITUED SODIUM CHANNEL BLOCKERS PARION SCIENCES, INC. (US) 2004-09-02 WO disclosed
CN-1520435-A Lipid-polymer-conjugates compsns. ֮��ŷ�����޹�˾ 2004-08-11 CN disclosed
CN-1337953-A Novel thyroid receptor ligands and method II KAROBIO AB (SE) 2002-02-27 CN disclosed
US-4273704-A N-Adamantane-substituted tetrapeptide amides G. D. SEARLE & CO. (US) 1981-06-16 US disclosed